Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia

Clinical trial NCT01960413 · COMPLETED

Trial details

NCT number: NCT01960413
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)

Start date: 2013-11-01
Primary completion: 2018-03-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.